Nanoformulated cell-penetrating survivin mutant and its dual actions
Bhasker Sriramoju, Rupinder K Kanwar, Jagat R Kanwar Nanomedicine Laboratory of Immunology and Molecular Biomedical Research (NLIMBR), School of Medicine, Faculty of Health, Deakin University, Geelong, Australia Abstract: In this study, we investigated the differential actions of a dominant-negat...
Guardado en:
Autores principales: | Sriramoju B, Kanwar RK, Kanwar JR |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0a1a3526d437406d81b5839afe1078d1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neurological disorders and therapeutics targeted to surmount the blood–brain barrier
por: Kanwar JR, et al.
Publicado: (2012) -
Competitive inhibition of survivin using a cell-permeable recombinant protein induces cancer-specific apoptosis in colon cancer model
por: Roy K, et al.
Publicado: (2015) -
Neurobehavioral burden of multiple sclerosis with nanotheranostics
por: Sriramoju B, et al.
Publicado: (2015) -
Molecular targets in arthritis and recent trends in nanotherapy
por: Roy K, et al.
Publicado: (2015) -
Oral administration of iron-saturated bovine lactoferrin–loaded ceramic nanocapsules for breast cancer therapy and influence on iron and calcium metabolism
por: Mahidhara G, et al.
Publicado: (2015)